anonymous
Guest
anonymous
Guest
The company knows that their future is biosimilars and generics. Rytary and Unithroid cannot sustain 2 sales teams who are not meeting annual sales projections. The Patel brothers need to take a hard look at who is running these teams. Hold Joe, Helen, Fernando, and Kelly accountable for the dismal sales numbers. There are no plans coming from this group other than the plans they have enforced on managers and reps.